Komori
Terumo (4543) · PolicyAdvanced

Reinvestment of Retained Earnings in Research and Development, Production Facilities and Overseas Expansion

First written in FY2016. 25 of 27 entries say "Advanced", first in FY2020-Q2. Latest entry: FY2026.

27entries
11years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY2019AdvancedFY2020-Q2 – FY20262016: 120162017: 020172018: 020182019: 220192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 32026
Same theme, other companies

30 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Cash used in investing activities totaled ¥344.1 billion. The main factors were ¥248.3 billion in expenditures for the acquisition of an affiliate or other business, including Organonox, Ltd. and the Leverkusen plant in Germany, and ¥85.2 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items.」

    Reinvestment in R&D, production facilities, overseas business and M&A continued, with ¥248.3 billion invested in acquisitions and ¥85.2 billion in property, plant and equipment.
  2. FY2026-H1AdvancedAnnual report

    「The main factors were ¥35.5 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, ¥26.3 billion in expenditures for the acquisition of an affiliate or other business, including the Leverkusen plant in Germany, and ¥6.5 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In FY2026-H1, investments of ¥35.5 billion in production facilities, ¥26.3 billion in the acquisition of businesses including the Leverkusen plant in Germany, and ¥6.5 billion in a new IT system and other items were made, continuing growth investments.
  3. FY2025AdvancedAnnual report

    「Cash used in investing activities totaled ¥82.5 billion. The main factors were ¥68.6 billion in expenditures for investments in production facilities and other items, and ¥13.7 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy emphasizing reinvestment in R&D, production facilities, IT and overseas business, investments in facilities and intangible assets continued. R&D expenses totaled ¥74.2 billion.
  4. FY2025-H1AdvancedAnnual report

    「Cash used in investing activities was ¥38.8 billion, compared with ¥36.1 billion in the same period of the previous year. The main factors were ¥31.7 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥6.9 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT and overseas business and other areas, investments in production facilities, a new IT system and other items continued.
  5. FY2024AdvancedAnnual report

    「Cash used in investing activities totaled ¥81.5 billion. The main factors were ¥60.7 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥18.0 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy of reallocating retained earnings to growth investments, investments were made including ¥60.7 billion in production facilities and ¥18.0 billion in a new IT system and other items.
  6. FY2024-Q3AdvancedAnnual report

    「Cash used in investing activities was ¥53.1 billion, compared with ¥41.9 billion in the same period of the previous year. The main factors were ¥40.4 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥13.4 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT and overseas business and other areas, investments in production facilities, a new IT system and other items continued through FY2024-Q3.
  7. FY2024-Q2AdvancedAnnual report

    「The main factors were ¥28.2 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥9.7 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT and overseas business and other areas, investments in production facilities, a new IT system and other items continued through FY2024-Q2.
  8. FY2024-Q1AdvancedAnnual report

    「The main factors were ¥14.7 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥4.5 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT and overseas business and other areas, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥19.2 billion in FY2024-Q1.
  9. FY2023AdvancedAnnual report

    「The main factors were ¥52.7 billion in expenditures for investments in production facilities and other items, and ¥19.5 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy of reinvesting internal funds and other resources in R&D, production facilities, IT and overseas business, FY2023 acquisition expenditures totaled ¥52.7 billion for property, plant and equipment and ¥19.5 billion for intangible assets.
  10. FY2023-Q3AdvancedAnnual report

    「Cash used in investing activities was ¥41.9 billion, compared with ¥59.3 billion in the same period of the previous year. The main factors were ¥38.0 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥14.7 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT and overseas business and other areas, investments in production facilities, a new IT system and other items continued.
  11. FY2023-Q2AdvancedAnnual report

    「Cash used in investing activities totaled ¥31.6 billion, compared with ¥40.5 billion used in the same period of the previous fiscal year. The main factors were ¥24.6 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥9.9 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy of reinvesting in R&D, production facilities, IT and overseas business and other areas, ¥24.6 billion was invested in production facilities and ¥9.9 billion in a new IT system and other items.
  12. FY2023-Q1AdvancedAnnual report

    「The main factors were ¥11.5 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥4.2 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy emphasizing reinvestment in R&D, production facilities, IT, overseas business and other areas, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥15.7 billion in the first quarter.
  13. FY2022AdvancedAnnual report

    「Cash used in investing activities totaled ¥78.5 billion. The main factors were ¥53.5 billion in expenditures for investments in production facilities and other items, and ¥20.6 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy of reinvesting in R&D, production facilities, IT and overseas business, investments were made including ¥53.5 billion in property, plant and equipment and ¥20.6 billion in intangible assets.
  14. FY2022-Q3AdvancedAnnual report

    「The main factors were ¥40.8 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥15.4 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the capital allocation policy emphasizing reinvestment in R&D, production facilities, IT, overseas business and other areas, cumulative acquisition expenditures totaled ¥56.2 billion through FY2022-Q3.
  15. FY2022-Q2AdvancedAnnual report

    「The main factors were ¥27.9 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥11.1 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the capital allocation policy of continuing growth investments, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥39.0 billion in FY2022-Q2.
  16. FY2022-Q1AdvancedAnnual report

    「The main factors were ¥14.1 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥5.9 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the policy of reinvesting in R&D, production facilities, IT and overseas business and other areas, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥20.0 billion in FY2022-Q1.
  17. FY2021AdvancedAnnual report

    「The main factors were ¥62.3 billion in expenditures for the acquisition of property, plant and equipment associated with investments in production facilities and other items, and ¥20.8 billion in expenditures for the acquisition of intangible assets associated with investment in a new IT system and other items.」

    In line with the policy of reinvesting retained earnings in R&D, production facilities, IT and overseas business, ¥62.3 billion was invested in production facilities and ¥20.8 billion in a new IT system and other items.
  18. FY2021-Q3AdvancedAnnual report

    「Cash used in investing activities was ¥63.0 billion, compared with ¥57.1 billion in the same period of the previous year. The main factors were ¥47.4 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥15.1 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy of continuing growth investments, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥62.5 billion through the third quarter.
  19. FY2021-Q2AdvancedAnnual report

    「The main factors were ¥32.9 billion in purchases of property, plant and equipment associated with investment in production equipment and other assets, and ¥11.7 billion in purchases of intangible assets associated with investment in a new IT system and other projects.」

    In line with the policy of reinvesting in R&D, production facilities, overseas business and other areas, cumulative acquisition expenditures for production facilities, a new IT system and other items totaled ¥44.6 billion in FY2021-Q2.
  20. FY2021-Q1AdvancedAnnual report

    「The main factors were ¥16.1 billion in purchases of property, plant and equipment associated with investments in production facilities and other assets, and ¥6.2 billion in purchases of intangible assets associated with investments in a new IT system and other assets.」

    In line with the capital allocation policy of continuing growth investments, acquisition expenditures totaling ¥22.3 billion were made in production facilities, a new IT system and other items in FY2021-Q1.
  21. FY2020AdvancedAnnual report

    「The main factors were ¥62.3 billion in expenditures for the acquisition of property, plant and equipment, including construction of a new building at Terumo Yamaguchi Corporation and capacity expansion, and ¥21.2 billion in expenditures for the acquisition of intangible assets, including investment in a new IT system and the acquisition of exclusive distribution rights.」

    In line with the policy of reinvesting internal funds and other resources in R&D, production facilities, IT and distribution rights, acquisition expenditures for property, plant and equipment and intangible assets totaled ¥83.5 billion.
  22. FY2020-Q3AdvancedAnnual report

    「The main factors were ¥39.7 billion in purchases of property, plant and equipment associated with the construction of a new building at Terumo Yamaguchi Corporation and capital expenditures to increase production, and ¥16.2 billion in purchases of intangible assets associated with investments in a new IT system and the acquisition of exclusive distribution rights.」

    In line with the policy of reinvesting in R&D, production facilities, overseas business and other areas, acquisition expenditures totaled ¥55.9 billion for production facilities, a new IT system, exclusive distribution rights and other items.
  23. FY2020-Q2AdvancedAnnual report

    「The main factors were ¥28.0 billion in purchases of property, plant and equipment associated with construction of a new building at Terumo Yamaguchi Co., Ltd. and other capacity expansion investments, and ¥10.8 billion in purchases of intangible assets associated with investment in a new IT system and the acquisition of exclusive distribution rights.」

    In line with the policy of reinvesting retained earnings in R&D, production facilities, overseas business and other areas, a total of ¥38.8 billion was invested in production facilities, a new IT system, exclusive distribution rights and other items.
  24. FY2019RestatedAnnual report

    「We will invest retained earnings effectively, focusing on R&D, expansion of production facilities and overseas business development, in order to strengthen our operating base.」

    Continues to state a capital allocation policy of reinvesting retained earnings in R&D, production facilities and overseas business.
  25. FY2016First statedAnnual report

    「We will invest retained earnings effectively, focusing on R&D, expansion of production facilities and overseas business development, in order to strengthen our operating base.」

    A capital allocation policy that sets out both shareholder returns and growth investments.
Moved together

"Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network" moved the same way as this thread, in the same document, in 24 of its 27 moves.

242221202020★123456
  1. ★This thread
  2. 1Strengthening Cost Competitiveness Through Products Tailored to Regional Needs and a Global Production Network24×
  3. 2Growth in the Blood Systems business centered on apheresis, cell processing and emerging markets22×
  4. 3Integration and Strengthening of the Global Production System, Including the Vietnam Factory21×
  5. 4Expanding market share in global markets and enhancing brand value20×
  6. 5Global sales expansion of cardiovascular products such as Ultimaster20×
  7. 6Consistent Dividend Growth and a Medium- to Long-Term Payout Ratio of 30%20×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Terumo yet. It last moved in the General Meetings of Shareholders of 2026-06-02: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reinvestment of Retained Earnings in Research and Development, Production Facilities and Overseas Expansion | TERUMO CORPORATION (4543) | Komori